Design, synthesis and evaluation of biological activities of some novel anti-TB agents with bio-reducible functional group

Hossein Khani-Meinagh ¹, Hossein Mostafavi ¹ * , Norbert Reiling ^2,3, Majid Mahdavi ⁴, Gholamreza Zarrini ⁴

Cited by CrossRef: 2

1- Rostampour S, Eslami F, Babaei E, Mostafavi H, Mahdavi M. An Active Compound from the Pyrazine Family Induces Apoptosis by Targeting the Bax/Bcl2 and Survivin Expression in Chronic Myeloid Leukemia K562 Cells. ACAMC. 2024;24(3):203 [Crossref]

2- Dhameliya T, Bhakhar K, Gajjar N, Patel K, Devani A, Hirani R. Recent advancements and developments in search of anti-tuberculosis agents: A quinquennial update and future directions. Journal of Molecular Structure. 2022;1248:131473 [Crossref]

3- Akhlaghi S, Mostoufi A, Kalantar H, Fereidoonnezhad M. Synthesis and biological evaluations of novel pyrazinoic acid derivatives as anticancer agents. Med Chem Res. 2022;31(4):580 [Crossref]

Submit Your Paper Instructions for Authors Aims and Scope Editorial Board Editorial Policies Publication Ethics Policies Editorial Board Policy Abstracting and Indexing Archive

As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences.
Acceptance rate: 24%
Publication fee: Free of charge

Indexing/Abstracting Info
PubMed; PubMed Central; Scopus; Science Citation Index Expanded, Google Scholar; SJR ; Essential Science Indicators; Publons; Embase; EBSCOhost; CAS: DOAJ: SHERPA/RoMEO; Ulrich
Member of COPE
Follower of ICMJE
Permission: Creative Commons